Phathom Pharmaceuticals(PHAT) - 2025 Q3 - Quarterly Report
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q For the transition period from to . Delaware 82-4151574 (State or other jurisdiction of incorporation or organization) 100 Campus Drive, Suite 102 Florham Park, New Jersey 07932 (Address of princi ...